Clinical Epidemiology Unit (CEU)
A | B | C
| D | E | F | G | H | I | J
| L | M | N | O | P | Q | R | S
| T | U | V | W
| X | Y | Z
- Castle, Philip E., Ph.D.
Dr. Castle’s interests are the science and translation of cancer prevention strategies; global health disparities research; epidemiology of human papillomaviruses (HPV) and cervical/anogenital cancer.
- Chaturvedi, Anil K., Ph.D.
Role of HPV in the etiology of head and neck cancers, natural history of head and neck cancer precursors, inflammation and cancer risk, role of inflammation in the etiology of lung cancer and other smoking-associated cancers.
- Clarke, Megan A., Ph.D., M.H.S.
Dr. Clarke conducts research combining molecular, clinical, and population-based approaches to address etiology, prevention, and early detection of anogenital, cervical, and endometrial cancers.
- Jeronimo, Jose A., M.D.
cervical cancer, lesion clonality, topography, visual natural history
- Katki, Hormuzd A., Ph.D.
Predicting cervical cancer risk. Estimating absolute risks from studies nested within cohorts. Efficient study designs for comparing diagnostic tests. Methodology for clinical genetics.
- Schiffman, Mark, M.D., M.P.H.
Molecular epidemiology to study the natural history of human papillomavirus infection on the risk of cervical cancer. Applications for cervical cancer prevention.
- Wentzensen, Nicolas, M.D., Ph.D.
Etiology of cervical, ovarian, and endometrial cancer. HPV - related carcinogenesis. Discovery and translation of biomarkers for gynecological cancers. Gene methylation.